UPDATE ON RIFAMPIN DRUG-INTERACTIONS .2.

被引:72
作者
BORCHERDING, SM
BACIEWICZ, AM
SELF, TH
机构
[1] UNIV TENNESSEE CTR HLTH SCI, DEPT CLIN PHARM, 26 S DUNLAP ST, SUITE 200, MEMPHIS, TN 38163 USA
[2] UNIV HOSP CLEVELAND, DEPT PHARM SERV, CLEVELAND, OH 44106 USA
关键词
D O I
10.1001/archinte.152.4.711
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rifampin is a potent inducer of hepatic P450 oxidative enzymes. Clinically important drug interactions have been documented between rifampin and numerous other drugs, such as oral anticoagulants, oral contraceptives, cyclosporine, digitalis, and ketoconazole. New, potentially clinically significant rifampin drug interactions have been reported for haloperidol, several antiarrhythmics, fluconazole, diltiazem, and select benzodiazepines. Further research has been conducted for previously reported drug interactions with rifampin involving such drugs as glucocorticoids, cyclosporine, verapamil, and oral anticoagulants. Proper management of these interactions is essential to avoid therapeutic failures on initiating rifampin therapy and potential toxic reactions after discontinuing rifampin. New rifampin drug interactions will continue to be identified with future investigations.
引用
收藏
页码:711 / 716
页数:6
相关论文
共 81 条
[1]   FAILURE OF KETOCONAZOLE TREATMENT OF BLASTOMYCES-DERMATIDIS DUE TO INTERACTION OF ISONIAZID AND RIFAMPIN [J].
ABADIEKEMMERLY, S ;
PANKEY, GA ;
DALVISIO, JR .
ANNALS OF INTERNAL MEDICINE, 1988, 109 (10) :844-845
[2]   PHENYTOIN INTERACTION WITH RIFAMPICIN [J].
ABAJO, FJ .
BRITISH MEDICAL JOURNAL, 1988, 297 (6655) :1048-1048
[3]   ATTENUATION OF RIFAMPICIN-INDUCED THEOPHYLLINE METABOLISM BY DILTIAZEM RIFAMPICIN COADMINISTRATION IN HEALTHY-VOLUNTEERS [J].
ADEBAYO, GI ;
AKINTONWA, A ;
MABADEJE, AFB .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 37 (02) :127-131
[4]   THE EFFECT OF ENZYME-INDUCTION ON THE METABOLISM OF DISOPYRAMIDE IN MAN [J].
AITIO, ML ;
MANSURY, L ;
TALA, E ;
HAATAJA, M ;
AITIO, A .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (03) :279-285
[5]   COMPLEX INTERACTION OF RIFAMPIN AND WARFARIN [J].
ALMOG, S ;
MARTINOWITZ, U ;
HALKIN, H ;
BANK, HZ ;
FARFEL, Z .
SOUTHERN MEDICAL JOURNAL, 1988, 81 (10) :1304-1306
[6]   SUCCESSFUL USE OF RIFAMPICIN IN THE TREATMENT OF TUBERCULOSIS IN RENAL-TRANSPLANT PATIENTS IMMUNOSUPPRESSED WITH CYCLOSPORINE [J].
ALSULAIMAN, MH ;
DHAR, JM ;
ALKHADER, AA .
TRANSPLANTATION, 1990, 50 (04) :597-598
[7]   INFLUENCES OF DIET AND NUTRITION ON CLINICAL PHARMACOKINETICS [J].
ANDERSON, KE .
CLINICAL PHARMACOKINETICS, 1988, 14 (06) :325-346
[8]   INDUCTION OF FLUCONAZOLE METABOLISM BY RIFAMPIN - INVIVO STUDY IN HUMANS [J].
APSELOFF, G ;
HILLIGOSS, DM ;
GARDNER, MJ ;
HENRY, EB ;
INSKEEP, PB ;
GERBER, N ;
LAZAR, JD .
JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (04) :358-361
[9]   RIFAMPIN DRUG-INTERACTIONS [J].
BACIEWICZ, AM ;
SELF, TH .
ARCHIVES OF INTERNAL MEDICINE, 1984, 144 (08) :1667-1671
[10]   UPDATE ON RIFAMPIN DRUG-INTERACTIONS [J].
BACIEWICZ, AM ;
SELF, TH ;
BEKEMEYER, WB .
ARCHIVES OF INTERNAL MEDICINE, 1987, 147 (03) :565-568